Sphingosine kinase 1 inhibition sensitizes hormone‐resistant prostate cancer to docetaxel
Lysann Sauer(Centre National de la Recherche Scientifique), Dmitri Pchejetski(University of East Anglia), Lenka Skalska(Imperial College London), João Nunes(Hospital de Câncer de Barretos), Vishal A. Salunkhe(Lund University), Takafumi Kohama(Daiichi-Sankyo (Japan)), Jonathan Waxman, Olivier Cuvillier(Centre National de la Recherche Scientifique)
Cited by 55
Related Papers
Sphingosine Kinase-1 as a Chemotherapy Sensor in Prostate Adenocarcinoma Cell and Mouse Models
|Cancer Research|2005|203
Oxidative Stress–Dependent Sphingosine Kinase-1 Inhibition Mediates Monoamine Oxidase A–Associated Cardiac Cell Apoptosis
|Circulation Research|2006|197
The emerging role of FTY720 (Fingolimod) in cancer treatment
|Oncotarget|2016|174
Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting shingosine kinase-1
|Leukemia|2005|171
Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1
|European Heart Journal|2011|163